학술논문
Phase II study of pegylated liposomal doxorubicin (Caelyx™) as induction chemotherapy for patients with squamous cell cancer of the head and neck
Document Type
Article
Author
Source
In European Journal of Cancer November 2001 37(16):2015-2022
Subject
Language
ISSN
0959-8049